SPEVIGO 450 mg, concentrate for solution for infusion 2 bottles of 7.5 ml
Active ingredients: SPÉSOLIMAB
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion2 bottles of 7.5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPEVIGO 450 mg, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre de 7,5 ml
- Marketing authorisation holder
- LEO PHARMA A/S (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
68300246CIP75509248CIP133400955092483Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPÉSOLIMABsolution | 450 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.